DiaMedica Therapeutics Inc. 8-K

What Happened

• On May 6, 2026, DiaMedica Therapeutics Inc. (DMAC) filed a Current Report on Form 8‑K under Item 2.02 to announce its condensed consolidated financial results for the quarter ended March 31, 2026. The company attached a press release dated May 6, 2026 (Exhibit 99.1) that provides a business update and the Q1 2026 financial results, and that press release is incorporated by reference into the filing.

Key Details

• Filing date: May 6, 2026; reporting period: quarter ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press release dated May 6, 2026 with business update and first-quarter 2026 financial results (furnished).
• Exhibit 104: Cover page provided in Inline XBRL format.

Why It Matters

• This 8‑K signals that DiaMedica has publicly released its latest quarterly earnings and financial condition. Retail investors should review the attached press release for the specific financial metrics (revenue, net income/loss, cash position, and any management comments or guidance), since those details can influence valuation and short‑term trading decisions.